We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICER Slams Cost-Effectiveness of Three Vertex Cystic Fibrosis Drugs
ICER Slams Cost-Effectiveness of Three Vertex Cystic Fibrosis Drugs
Significant price cuts would be needed for three Vertex cystic fibrosis drugs to deliver benefits equal to their cost, according to an analysis by the Institute of Clinical and Economic Review.